ZAI LAB LIMITED Inventory, Work in Process, Gross
ZAI LAB LIMITED (ZLAB) had Inventory, Work in Process, Gross of $31.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2022-11-09
- 2022-09-30: Inventory, Work in Process, Gross $31.00K.
- 2022-06-30: Inventory, Work in Process, Gross $521.00K.
- 2022-03-31: Inventory, Work in Process, Gross $0.00.
- 2021-12-31: Inventory, Work in Process, Gross $88.00K.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2022-09-30 | $31.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $521.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 |
| 2021-12-31 | $88.00K 10-Q · filed 2022-11-09 |
| 2021-06-30 | $368.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $338.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $0.00 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |